Forge Biologics
Latest round
- Series C
Last raised
- Sep 2022
Total raised
- $250M
Investors
- 7
About Forge Biologics
Based in Ohio, US, and founded in 2020, Forge Biologics, Inc. offers end-to-end manufacturing services of gene therapy for patients with genetic diseases. The company was co-founded by Erandi De Silva, Jaysson Eicholtz, and Timothy J Miller., Inc. acquired Forge Biologics, Inc.. from Drive Capital, Aisling Capital, MidCap Financial, Surveyor Capital, RA Capital, Perceptive Advisors, Octagon Capital Investments, and Marshall Wace for USD 620 million. Upon completion of the transaction which will be by the end of 2023, Forge Biologics, Inc., Inc. The company offers gene therapy manufacturing and therapeutics development to accelerate and develop medicines for rare genetic diseases. Forge Biologics, Inc. offers end-to-end manufacturing and development services to launch gene therapy programs from pre-clinical stage, clinical, and commercial manufacturing. The company works with pharmaceutical companies, by offering novel therapies for genetic diseases.'s acquisition will enable Forge Biologics, Inc. to further develop its capabilities and platform and expand globally.
Who invested in Forge Biologics
7 investors across 3 rounds
See all investors in Forge Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Forge Biologics
Who invested in Forge Biologics?
Forge Biologics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Forge Biologics raised?
Forge Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Forge Biologics last raise money?
Forge Biologics's most recent round on record is a Series C, in Sep 2022.
What does Forge Biologics do?
Based in Ohio, US, and founded in 2020, Forge Biologics, Inc.
Where is Forge Biologics headquartered?
Forge Biologics is headquartered in Grove City, US.
Which VCs invest in companies like Forge Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Forge Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Forge Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.